Zinc associated nanomaterials and their intervention in emerging respiratory viruses: Journey to the field of biomedicine and biomaterials.

Respiratory viruses represent a severe public health risk worldwide, and the research contribution to tackle the current pandemic caused by the SARS-CoV-2 is one of the main targets among the scientific community. In this regard, experts from different fields have gathered to confront this catastrophic pandemic. This review illustrates how nanotechnology intervention could be valuable in solving this difficult situation, and the state of the art of Zn-based nanostructures are discussed in detail. For virus detection, learning from the experience of other respiratory viruses such as influenza, the potential use of Zn nanomaterials as suitable sensing platforms to recognize the S1 spike protein in SARS-CoV-2 are shown. Furthermore, a discussion about the antiviral mechanisms reported for ZnO nanostructures is included, which can help develop surface disinfectants and protective coatings. At the same time, the properties of Zn-based materials as supplements for reducing viral activity and the recovery of infected patients are illustrated. Within the scope of noble adjuvants to improve the immune response, the ZnO NPs properties as immunomodulators are explained, and potential prototypes of nanoengineered particles with metallic cations (like Zn2+) are suggested. Therefore, using Zn-associated nanomaterials from detection to disinfection, supplementation, and immunomodulation opens a wide area of opportunities to combat these emerging respiratory viruses. Finally, the attractive properties of these nanomaterials can be extrapolated to new clinical challenges

Zinc associated nanomaterials and their intervention in emerging respiratory viruses:Journey to the field of biomedicine and biomaterials

Respiratory viruses represent a severe public health risk worldwide, and the research contribution to tackle the current pandemic caused by the SARS-CoV-2 is one of the main targets among the scientific community. In this regard, experts from different fields have gathered to confront this catastrophic pandemic. This review illustrates how nanotechnology intervention could be valuable in solving this difficult situation, and the state of the art of Zn-based nanostructures are discussed in detail. For virus detection, learning from the experience of other respiratory viruses such as influenza, the potential use of Zn nanomaterials as suitable sensing platforms to recognize the S1 spike protein in SARS-CoV-2 are shown. Furthermore, a discussion about the antiviral mechanisms reported for ZnO nanostructures is included, which can help develop surface disinfectants and protective coatings. At the same time, the properties of Zn-based materials as supplements for reducing viral activity and the recovery of infected patients are illustrated. Within the scope of noble adjuvants to improve the immune response, the ZnO NPs properties as immunomodulators are explained, and potential prototypes of nanoengineered particles with metallic cations (like Zn(2+)) are suggested. Therefore, using Zn-associated nanomaterials from detection to disinfection, supplementation, and immunomodulation opens a wide area of opportunities to combat these emerging respiratory viruses. Finally, the attractive properties of these nanomaterials can be extrapolated to new clinical challenges

Anticipating Challenges in Optical Nanobiosensors for Global Detection of Respiratory Viruses and Emerging Threats

The unprecedented SARS-CoV-2 pandemic has opened huge opportunities for nanomaterial-based biosensors focused on timely detection of emerging respiratory viruses, where challenges must address actions for fast response and massive application. Accordingly, we provide a comprehensive perspective on critical aspects, including nanomaterials, biofunctionalization strategies, and bioreceptors engineering to increase accuracy, emphasizing optical nanobiosensors. The first biosensing prototype performance reveals the need to consider crucial factors for improvement, such as handling detection in complex matrices, standardization for commercial purposes, portability, integration with artificial intelligence, sustainability, and economic feasibility. By achieving these goals, biosensors would foster a prepared global healthcare landscape

Interaction Study of Anti‐E. coli Immobilization on 1DZnO at Nanoscale for Optical Biosensing Application

Abstract Developing low‐cost biosensing platforms for robust detection response and sensitivity at low concentrations is of great interest. This work reports synthesizing 1D ZnO nanostructured materials (1DZnO) with controllable properties utilizing a metal catalyst‐assisted vapor phase growth technique (VLS). The obtained materials are functionalized with (3‐aminopropyl) trimetoxysilane (APTMS) and immobilized with anti‐Escherichia coli enteropathogenic (EPEC) antibodies. Characterization results show changes in the optical and structural properties of 1DZnO that are correlated with the biofunctionalization methodologies. Further, the biofunctionalization process is assessed on 1DZnO surface platforms to obtain acceptable antibody immobilization efficiencies (52%, 96%, and 100%) using a low‐concentration antibody solution (30 µg ml−1). Special techniques such as focused ion beam micromachining and scanning tunneling electron microscopy are proposed to appreciate the semiconductor biofunctionalization layer around 1DZnO and explain the physics of the interaction process. It is found that morphology obtained from distinct synthesis methods, solvents, and functionalization agents can generate functional groups for biomolecule attachment. Remarkably, it is demonstrated that biofunctionalization on 1DZnO takes place all over a single nanostructure. This work presents a proof‐of‐concept focused on generating pathogen sensing platforms using 1DznO semiconducting materials, providing new insights into bio‐analytes interaction with structures at the nanoscale

First multicenter experience using the Silk Vista flow diverter in 60 consecutive intracranial aneurysms: technical aspects

International audienceBackground The aim of this study was to assess the technical success and procedural safety of the new Silk Vista device (SV) by evaluating the intraprocedural and periprocedural complication rate after its use in several institutions worldwide. Methods The study involved a retrospective review of multicenter data regarding a consecutive series of patients with intracranial aneurysms, treated with the SV between September 2020 and January 2021. Clinical, intra/periprocedural and angiographic data, including approach, materials used, aneurysm size and location, device/s, technical details and initial angiographic aneurysm occlusion, were analyzed. Results 60 aneurysms were treated with SV in 57 procedures. 66 devices were used, 3 removed and 63 implanted. The devices opened instantaneously in 60 out of 66 (91%) cases and complete wall apposition was achieved in 58 out of 63 (92%) devices implanted. In 4 out of 66 (6%) devices a partial opening of the distal end occurred, and in 5 (8%) devices incomplete apposition was reported. There were 3 (5%) intraprocedural thromboembolic events managed successfully with no permanent neurological morbidity, and 4 (7%) postprocedural events. There was no mortality in this study. The initial occlusion rates in the 60 aneurysms were as follows: O’Kelly–Marotta (OKM) A in 34 (57%) cases, OKM B in 15 (25%) cases, OKM C in 6 (10%) cases, and OKM D in 5 (8%) cases. Conclusions Our study demonstrated that the use of the new flow diverter Silk Vista for the treatment of intracranial aneurysms is feasible and technically safe